FI
Fosun International Portfolio holdings
AUM
$360M
This Quarter Return
+12.61%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.57B
AUM Growth
+$1.57B
(-6%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-16.83%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
343
New
45
Increased
88
Reduced
68
Closed
37
Top Buys
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
MOMO
Hello Group
MOMO
|
$6.36M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 4 |
BBU
Brookfield Business Partners
BBU
|
$3.38M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.34M |
Top Sells
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
$94.3M |
| 2 |
Vipshop
VIPS
|
$53.6M |
| 3 |
DigitalBridge
DBRG
|
$37.5M |
| 4 |
Brookdale Senior Living
BKD
|
$33.9M |
| 5 |
Criteo
CRTO
|
$15.3M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Newmont
NEM
$82.8B
| $3.58M | 0.23% |
100,690
+79,490
| +375% | +$2.83M |
|
|
BBU
52
Brookfield Business Partners
BBU
$2.37B
| $3.38M | 0.21% |
+48,530
| New | +$3.38M |
|
53
Xoma
XOMA
$421M
| $3.35M | 0.21% |
269,877
-46,357
| -15% | -$575K |
|
54
Cognizant
CTSH
$35.1B
| $3.31M | 0.21% |
46,250
| – | – |
|
|
STML
55
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.29M | 0.21% |
267,936
+209,936
| +362% | +$2.58M |
|
56
Berkshire Hathaway Class B
BRK.B
$1.08T
| $3.17M | 0.2% |
15,800
-900
| -5% | -$181K |
|
57
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.15M | 0.2% |
46,144
+21,144
| +85% | +$1.44M |
|
|
ALDR
58
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $3.11M | 0.2% |
233,858
+49,045
| +27% | +$653K |
|
59
Cerus
CERS
$251M
| $3.09M | 0.2% |
498,538
| – | – |
|
60
Microsoft
MSFT
$3.76T
| $3.08M | 0.2% |
26,325
-22,623
| -46% | -$2.65M |
|
|
HARP
61
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.06M | 0.19% |
+323,400
| New | +$3.06M |
|
62
Ares Capital
ARCC
$15.7B
| $3.06M | 0.19% |
178,707
+50,000
| +39% | +$856K |
|
|
CFRX
63
DELISTED
ContraFect Corporation
CFRX
| $2.98M | 0.19% |
7,453,857
-2,100
| -0% | -$960 |
|
|
DCPH
64
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.97M | 0.19% |
128,037
| – | – |
|
65
Alphabet (Google) Class C
GOOG
$2.79T
| $2.83M | 0.18% |
2,421
+500
| +26% | +$584K |
|
|
LJPC
66
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.74M | 0.17% |
416,260
+107,610
| +35% | +$709K |
|
67
UnitedHealth
UNH
$279B
| $2.73M | 0.17% |
11,270
-20
| -0.2% | -$4.85K |
|
|
MYOK
68
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.7M | 0.17% |
51,967
+25,454
| +96% | +$1.32M |
|
69
Medtronic
MDT
$118B
| $2.68M | 0.17% |
+29,800
| New | +$2.68M |
|
|
DRNA
70
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.67M | 0.17% |
188,673
+74,735
| +66% | +$1.06M |
|
71
HDFC Bank
HDB
$181B
| $2.64M | 0.17% |
23,260
+4,940
| +27% | +$561K |
|
72
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $2.64M | 0.17% |
192,248
+126,748
| +194% | +$1.74M |
|
73
Altria Group
MO
$112B
| $2.63M | 0.17% |
46,347
+15,547
| +50% | +$883K |
|
|
PTLA
74
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.51M | 0.16% |
74,800
| – | – |
|
|
OBSV
75
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $2.49M | 0.16% |
+194,991
| New | +$2.49M |
|